Table 3:
Progression Free Survival and Overall Survival
| Progression free survival | Overall survival | |||||||
|---|---|---|---|---|---|---|---|---|
| Univariable | Adjusted | Univariable | Adjusted | |||||
| HR (95%CI) | p-val | HR (95%CI) | p-val | HR (95%CI) | p-val | HR (95%CI) | p-val | |
| ECE | 2.48(0.78–7.94) | 0.13 | 1.37(0.39–4.87) | 0.63 | 1.36(0.62–2.96) | 0.44 | 0.98(0.40–2.37) | 0.96 |
| 3+ positive LNs | 5.33(1.76–16.20) | 0.003 | 3.65(1.09–12.31) | 0.036 | 3.05(1.36–6.89) | 0.007 | 2.70(1.13–6.43) | 0.025 |
| Largest LN (per 1cm increase) | 1.25(0.99–1.56) | 0.059 | 1.08(0.81–1.43) | 0.6 | 1.16(0.98–1.37) | 0.087 | 1.09(0.89–1.31) | 0.44 |
| Positive margin | 0.98(0.21–4.46) | 0.98 | 0.91(0.19–4.26) | 0.9 | 2.82(0.99–8.01) | 0.052 | 2.90(0.98–8.60) | 0.055 |
| Chemotherapy | 3.48(1.21–9.98) | 0.021 | 2.23(0.73–6.83) | 0.16 | 1.63(0.70–3.75) | 0.26 | 1.15(0.49–2.75) | 0.74 |